跳至主要内容
临床试验/NCT03123289
NCT03123289终止2 期

Novel Gallium 68 Citrate in Orthopedic Infections

Rutgers, The State University of New Jersey1 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2017年3月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
1
试验地点
1
主要终点
68Gallium-citrate and 18F-FDG uptake (SUV) surrounding the femoral and acetabular components of the prosthesis

研究概览

简要总结

In the proposed study, our aim is to evaluate the uptake of 68Gallium-citrate in patients with failed joint prosthesis and compare it with that of conventional 18fluorine-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) scan. We will perform PET/CT scan with 68Gallium citrate and 18F-FDG in subjects with failed hip or knee prosthesis. Both 68Gallium-citrate and 18F-FDG scans, done within 24-48 hours from each other, will be performed within 4 weeks before surgical evaluation/revision of the hardware.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least 6 months after hip replacement with complaint of joint pain.
  • Radiographic studies compatible with prosthesis loosening (i.e. periprosthetic infection or aseptic loosening).
  • Pending surgical evaluation and tissue sampling within the next few weeks to differentiate between infection and aseptic loosening.

排除标准

  • Inability to consent
  • Pregnancy or known or suspected hypersensitivity to metals or gallium
  • Joint replacement for any reason other than primary or secondary osteoarthritis
  • Prior surgical therapy for prosthesis failure after initial hospital discharge
  • Active inflammatory/infectious process at any location other than prosthetic joint (Sarcoidosis, Rheumatoid arthritis, HIV infection, SLE)

研究组 & 干预措施

68Gallium-citrate

Experimental

This arm, undergoing the "68-Gallium citrate PET/CT scan intervention", includes the PET/CT scans performed with 68Gallium-citrate radiotracer. Note that same patients scanned with different radiotracers serve in both arms.

干预措施: 68-Gallium citrate PET/CT scan (Drug)

18F-FDG

Experimental

This arm, undergoing the "18F FDG PET/CT scan intervention", includes the PET/CT scans performed with 18F-FDG tracer.

Note that same patients scanned with different radiotracers serve in both arms.

干预措施: 18F FDG PET/CT scan (Drug)

结局指标

主要结局

68Gallium-citrate and 18F-FDG uptake (SUV) surrounding the femoral and acetabular components of the prosthesis

时间窗: 1 year

The radiotracer uptake in SUV units is measured in different Gruen zones around the prosthesis and normalized by that of the liver. The values of the two scans will be compared against each other for all patients.

次要结局

  • Sensitivity, specificity, and accuracy of 68Gallium-citrate and 18F-FDG scans, by using surgical pathology results as the gold standard.(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nasrin Ghesani

Associate Professor

Icahn School of Medicine at Mount Sinai

研究点 (1)

Loading locations...

相似试验